HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide - Luznik, L; O’Donnell, P V; Symons, H J (Biol Blood Marrow Transplant, 2008)
et al.